What is the recommended dose of Benadryl (diphenhydramine) for a 28 kg male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl (Diphenhydramine) Dosing for a 28 kg Male

For a 28 kg male, the recommended dose of diphenhydramine is 1 mg/kg, which equals 28 mg, given orally, intramuscularly, or intravenously depending on the clinical indication. 1

Standard Dosing Guidelines

The weight-based dosing for diphenhydramine in pediatric patients is consistently reported as 1 mg/kg per dose across multiple high-quality guidelines 1, 2:

  • For this 28 kg patient: 28 mg per dose
  • Maximum single dose should not exceed 50 mg 1, 2
  • Can be administered every 6 hours as needed 3

Route-Specific Considerations

Oral Administration

  • Standard dose: 1 mg/kg (28 mg for this patient) 1
  • Liquid formulations are preferred over tablets for more rapid absorption in acute allergic reactions 4

Intravenous/Intramuscular Administration

  • Dose range: 1-2 mg/kg 1, 2
  • For this patient: 28-56 mg (not to exceed 50 mg maximum) 1, 2
  • Critical safety warning: IV diphenhydramine must be administered slowly to avoid hypotension, cardiac toxicity, and other serious adverse effects 3
  • When given IV for infusion reactions, administer slowly at 25-50 mg 1

Clinical Context Matters

For Premedication (e.g., before chemotherapy or immunosuppressive therapy)

  • Use 1 mg/kg IV or PO 1
  • For this 28 kg patient: 28 mg

For Acute Allergic Reactions or Anaphylaxis

  • Diphenhydramine is adjunctive therapy only and should never replace epinephrine 1, 4
  • Dose: 1-2 mg/kg IV slowly (maximum 50 mg) 1
  • For this patient: 28-50 mg IV slowly
  • Epinephrine remains the first-line treatment for anaphylaxis 1

For Prevention of Akathisia (with prochlorperazine)

  • Dose: 1-2 mg/kg (maximum 50 mg) 2
  • For this patient: 28-50 mg

Important Safety Considerations and Caveats

Modern evidence strongly suggests moving away from diphenhydramine when alternatives exist 5, 6:

  • Second-generation antihistamines (cetirizine, loratadine, fexofenadine) have superior safety profiles with equal efficacy 4, 5
  • Diphenhydramine causes significant sedation, anticholinergic effects, and carries risk of cardiac toxicity in overdose 5, 3, 6
  • Some countries (Germany, Sweden) have restricted access to first-generation antihistamines due to safety concerns 6

Adverse Effects to Monitor

  • Excessive sedation and impaired psychomotor performance 7, 3
  • Anticholinergic effects: dry mouth, blurred vision, urinary retention, constipation 7
  • Cardiovascular effects: hypotension (especially with rapid IV administration), tachycardia 7, 3
  • Risk of delirium and confusion 7

When to Avoid Diphenhydramine

  • Children under 6 years: FDA and AAP recommend against routine use due to 33 deaths associated with diphenhydramine in children under 6 years between 1969-2006 4
  • Consider second-generation antihistamines as first-line for routine allergic symptoms 4, 5

Practical Algorithm

  1. Determine indication: Is this for acute anaphylaxis, premedication, or routine allergic symptoms?
  2. If anaphylaxis: Give epinephrine first, then diphenhydramine 1-2 mg/kg IV slowly (28-50 mg) as adjunct 1
  3. If premedication or routine use: Consider second-generation antihistamines first 4, 5
  4. If diphenhydramine is chosen: Use 1 mg/kg (28 mg) PO/IM/IV 1
  5. Monitor closely for sedation and anticholinergic effects 7, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diphenhydramine Dosing for Prevention of Prochlorperazine-Induced Akathisia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diphenhydramine: A Review of Its Clinical Applications and Potential Adverse Effect Profile.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Guideline

Antihistamine Dosing for Pediatric Allergic Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diphenhydramine: Time to Move on?

The journal of allergy and clinical immunology. In practice, 2022

Research

Diphenhydramine: It is time to say a final goodbye.

The World Allergy Organization journal, 2025

Guideline

Diphenhydramine Use in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.